!

COVID-19 Response

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Michael Ittmann Lab

FGFR-4 in Prostate Cancer

Master
Media Component
Immunohistochemistry with anti-FGFR-4 antibody showing strong staining in prostate cancer cells.
Content

Recent studies in our laboratory have shown that a germline polymorphism of the FGFR-4 gene resulting in expression of arginine at codon 388 (Arg388 ) is associated with prostate cancer incidence and the occurrence of aggressive disease. The FGFR-4 genotype of men undergoing radical prostatectomy and controls of the same race was determined and the genotype correlated with clinical and pathological parameters. The presence of the FGFR-4 Arg388 allele is strongly associated with the occurrence of prostate cancer in white men and is also correlated with both increased pathological stage and the occurrence of pelvic lymph node metastasis in men undergoing radical prostatectomy. Expression of FGFR-4 Arg388 in immortalized prostatic epithelial cells results in increased cell motility and invasion through Matrigel when compared to cells expressing the FGFR-4 Gly388 allele. Thus, presence of the FGFR-4 Arg388 allele is associated with both an increased incidence and clinical aggressiveness of prostate cancer and results in increased cellular motility and invasiveness in immortalized prostate epithelial cells.

Heading

Current Efforts

Content
  • Directly testing the ability of the FGFR-4 Arg388 allele to promote metastasis in vivo using transgenic and orthotopic mouse models of prostate cancer
  • Determination of the mechanism by which the FGFR-4 Arg388 allele promotes increased motility and metastasis
  • Confirming the role of the FGFR-4 Arg388 allele in prostate cancer incidence in a prospective trial and analysis of its impact on patient outcome in men treated with radiation therapy or watchful waiting
Heading

Related Publications

Content

Wang J, Stockton D, and Ittmann M. 2004. The FGFR-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin Cancer Res. 10: 6169-6178.

Ropiquet F, Giri D, Kwabi-Addo, B, Mansukhani A, and Ittmann M. 2000. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Cancer Res. 60: 4245-4250.